306
Participants
Start Date
November 23, 2016
Primary Completion Date
November 12, 2021
Study Completion Date
November 12, 2021
Enapotamab vedotin (HuMax-AXL-ADC)
Enapotamab vedotin (HuMax-AXL-ADC) will be administered intravenously.
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam
Universitair Ziekenhuis Brussel - Oncologisch Centrum, Jette
Institut Roi Albert II - Cliniques Universitaires Saint Luc, Brussels
Leiden University Medical Centre, Leiden
Universitair Ziekenhuizen Leuven, Leuven
U.Z. Leuven Gasthuisberg, Department of General Medical Oncology, Leuven
Erasmus MC, Medical Oncology, Rotterdam
UMC Utrecht Cancer Center, Utrecht
CHU de Liège, Medical Oncology et. Domaine Universitaire du Sart Tilman, Liège
Medische oncologie, Oncologisch Centrum - AZ Groeninge, Kortrijk
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
Herbert Irving Comprehensive Cancer Center, New York
Roswell Park Comprehensive Cancer Center, Buffalo
University Hospital of Girona, Girona
Fox Chase Cancer Center, Philadelphia
Duke Cancer Institute, Durham
Hospital Universitario 12 Octubre Servicio de Oncologia Medica, Madrid
Hospital Virgen de la Victoria, Málaga
Emory University School of Medicine, Winship Cancer Institute, Atlanta
Mayo Clinic Jacksonville, Jacksonville
Moffitt Cancer Center, Tampa
University of Michigan Comprehensive Cancer Center, Ann Arbor
University Hospital Lozano Blesa, Aragón Health Research Institute (IIS Aragón), Zaragoza
University of Iowa, Iowa City
University of Wisconsin Carbone Cancer Center, Madison
Mayo Clinic Rochester, Rochester
Washington University, St Louis
Mary Crowley Cancer Research Center, Dallas
University of Texas MD Anderson Cancer Center, Houston
University of Colorado Hospital, Aurora
University of Utah Huntsman Cancer Institute, Salt Lake City
Mayo Clinic - Phoenix, Phoenix
Yale University, Smilow Cancer Center at Yale New Haven Hospital, New Haven
Dana-Farber Cancer Institute, Boston
Rigshospitalet, Copenhagen University Hospital, Copenhagen
Hospital Unversitario Vall D'hebron, Barcelona
Oncologia Mèdica/ Medical Oncology Department Institut Catalá d'Oncologia (ICO), Barcelona
University College London Hospitals, London
The Christie NHS Foundation Trust Clinical Trials Unit, Manchester
Sir Bobby Robson Clinical Trials Unit at the Northern Centre for Cancer Care, Freeman Hospital, Newcastle
The Royal Marsden Hospital, Sutton
Lead Sponsor
Genmab
INDUSTRY